220 related articles for article (PubMed ID: 12557178)
21. Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B.
Cainelli F; Longhi MS; Concia E; Vento S
Am J Gastroenterol; 2001 May; 96(5):1651-2. PubMed ID: 11374725
[No Abstract] [Full Text] [Related]
22. Combined lamivudine and interferon-alpha therapy for chemotherapy-induced reactivation of hepatitis B virus.
Ohmoto K; Tsuduki M; Yamamoto S
Am J Gastroenterol; 2003 May; 98(5):1215-6; author reply 1217. PubMed ID: 12809863
[No Abstract] [Full Text] [Related]
23. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM
J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
[TBL] [Abstract][Full Text] [Related]
24. Tenofovir therapy for lamivudine resistance following liver transplantation.
Neff GW; Nery J; Lau DT; O'Brien CB; Duncan R; Shire NJ; Ruiz P; Nery C; Montalbano M; Muslu H; Safdar K; Schiff ER; Tzakis AG; Madariaga JR
Ann Pharmacother; 2004 Dec; 38(12):1999-2004. PubMed ID: 15507498
[TBL] [Abstract][Full Text] [Related]
25. Drug-resistant viral hepatitis.
Wright M; Main J; Thomas HC
J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
[No Abstract] [Full Text] [Related]
26. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
[No Abstract] [Full Text] [Related]
27. Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.
Kuwahara R; Kumashiro R; Inoue H; Tanabe R; Tanaka E; Hino T; Ide T; Koga Y; Sata M
Dig Dis Sci; 2004 Feb; 49(2):300-3. PubMed ID: 15104374
[No Abstract] [Full Text] [Related]
28. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
[TBL] [Abstract][Full Text] [Related]
30. Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
Panos GZ; Lampropoulos KM; Angelousi AG; Charatsis GG; Falagas ME
J Clin Gastroenterol; 2007 Feb; 41(2):222-3. PubMed ID: 17245225
[No Abstract] [Full Text] [Related]
31. Hepatitis B virus resistance to antivirals: clinical implications and management.
Zoulim F
J Hepatol; 2003; 39 Suppl 1():S133-8. PubMed ID: 14708691
[No Abstract] [Full Text] [Related]
32. Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: experience of 2 cases.
Nakagawa M; Simizu Y; Suemura M; Sato B
Am J Hematol; 2002 May; 70(1):60-3. PubMed ID: 11994984
[TBL] [Abstract][Full Text] [Related]
33. [Lamivudine resistance impedes hepatitis B therapy].
Eggers HJ
Fortschr Med; 1997 Apr; 115(12):5. PubMed ID: 9235306
[No Abstract] [Full Text] [Related]
34. Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD.
Hilgendorf I; Loebermann M; Borchert K; Junghanss C; Freund M; Schmitt M
Bone Marrow Transplant; 2011 Sep; 46(9):1274-5. PubMed ID: 21151183
[No Abstract] [Full Text] [Related]
35. [Current treatment of hepatitis B].
Suárez García E; Romero Gómez M; Grande Santamaría L
Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():35-50. PubMed ID: 11279893
[No Abstract] [Full Text] [Related]
36. Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
Enomoto M; Nishiguchi S; Seki S; Yamane T; Hino M
Am J Gastroenterol; 2004 Aug; 99(8):1619-20. PubMed ID: 15307884
[No Abstract] [Full Text] [Related]
37. [Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
Shtalrid M; Haran M; Klepfish A; Lurie Y; Malnick S
Harefuah; 2001 Dec; 140(12):1159-62, 1230, 1229. PubMed ID: 11789300
[TBL] [Abstract][Full Text] [Related]
38. Lamivudine for the prevention of hepatitis B virus reactivation during autologous stem cell transplantation. A case report.
Silvestri F; Sperotto A; Ermacora A; Fanin R; Damiani D; Baccarani M
Haematologica; 2000 Mar; 85(3):327-9. PubMed ID: 10702831
[No Abstract] [Full Text] [Related]
39. Controversies about the treatment of hepatitis B (lamivudine, interferon, a combination or more?).
Desai HG; Chowdhury A
Trop Gastroenterol; 2003; 24(3):157-60. PubMed ID: 14978995
[No Abstract] [Full Text] [Related]
40. [Treatment of liver cirrhosis due to hepatitis B with lamivudine].
Castellano G; Fernández I; Jiménez C; Solís Herruzo JA
Gastroenterol Hepatol; 1999 Oct; 22(8):433-4. PubMed ID: 10592680
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
